Literature DB >> 6179537

Neutralizing monoclonal antibody specific for Naja nigricollis toxin alpha: preparation, characterization, and localization of the antigenic binding site.

J C Boulain, A Ménez, J Couderc, G Faure, P Liacopoulos, P Fromageot.   

Abstract

One homogeneous population of high-affinity monoclonal antibodies (KD = 0.35 nM) specific for Naja nigricollis toxin alpha has been produced. It neutralizes the biological activity of the toxin under both the vivo and in vitro conditions. The molecular zone of the toxin to which the antibody binds has been precisely defined on the basis of cross-reaction experiments using five derivative of toxin alpha monomodified at a single amino group and two naturally occurring homologous toxins. The epitope is located at the base of the first beta-sheet loop of the toxin, involving the two positive charges at the N-terminal position and lysine-15 proline-18, and probably threonine-16. It is shown that this region is topographically distinct from the "toxic" site of toxin alpha. Several possibilities are offered to explain the mechanisms(s) of specific neutralization.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6179537     DOI: 10.1021/bi00541a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 113-120 (antigenic site 4) of myoglobin.

Authors:  M S Abaza; M Z Atassi
Journal:  J Protein Chem       Date:  1992-12

2.  Functional analysis of the effect of monoclonal antibodies on monkey liver phenylalanine hydroxylase.

Authors:  I G Jennings; R G Russell; W L Armarego; R G Cotton
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

3.  Topography of toxin-acetylcholine receptor complexes by using photoactivatable toxin derivatives.

Authors:  B Chatrenet; O Trémeau; F Bontems; M P Goeldner; C G Hirth; A Ménez
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

4.  Structure-activity studies of homologues of short chain neurotoxins from Elapid snake venoms.

Authors:  A L Harvey; R C Hider; S J Hodges; F J Joubert
Journal:  Br J Pharmacol       Date:  1984-07       Impact factor: 8.739

5.  The effects of specific antibody fragments on the 'irreversible' neurotoxicity induced by Brown snake (Pseudonaja) venom.

Authors:  R G Jones; L Lee; J Landon
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Integrating Engineering, Manufacturing, and Regulatory Considerations in the Development of Novel Antivenoms.

Authors:  Andreas Hougaard Laustsen; Netty Dorrestijn
Journal:  Toxins (Basel)       Date:  2018-07-31       Impact factor: 4.546

7.  Bibliometric Analysis of Literature in Snake Venom-Related Research Worldwide (1933-2022).

Authors:  Fajar Sofyantoro; Donan Satria Yudha; Kenny Lischer; Tri Rini Nuringtyas; Wahyu Aristyaning Putri; Wisnu Ananta Kusuma; Yekti Asih Purwestri; Respati Tri Swasono
Journal:  Animals (Basel)       Date:  2022-08-12       Impact factor: 3.231

Review 8.  Antibodies as Snakebite Antivenoms: Past and Future.

Authors:  Wilmar Dias da Silva; Sonia A De Andrade; Ângela Alice Amadeu Megale; Daniel Alexandre De Souza; Osvaldo Augusto Sant'Anna; Fábio Carlos Magnoli; Felipe Raimondi Guidolin; Kemily Stephanie Godoi; Lucas Yuri Saladini; Patrick Jack Spencer; Fernanda Calheta Vieira Portaro
Journal:  Toxins (Basel)       Date:  2022-09-01       Impact factor: 5.075

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.